Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,477 | -89,988 | -55,496 | -26,693 | -60,366 |
| Depreciation Amortization | 2,133 | 1,570 | 1,012 | 482 | 1,707 |
| Accounts payable and accrued liabilities | 736 | 6,034 | 967 | 3,068 | 4,083 |
| Other Working Capital | 7,857 | 7,823 | 2,570 | -1,838 | 3,424 |
| Other Operating Activity | 2,501 | -2,628 | 1,247 | -544 | -1,258 |
| Operating Cash Flow | $-114,250 | $-77,189 | $-49,700 | $-25,525 | $-52,410 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -158,697 | -188,451 | -189,229 | -122,336 | -8,164 |
| PPE Investments | -2,205 | -1,673 | -1,571 | -543 | -621 |
| Investing Cash Flow | $-160,902 | $-190,124 | $-190,800 | $-122,879 | $-8,785 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 59,900 |
| Debt Repayment | -956 | -709 | -467 | -231 | -781 |
| Common Stock Issued | 341,430 | 341,398 | 341,308 | 341,235 | 645 |
| Other Financing Activity | -3,361 | -3,361 | -3,361 | -2,955 | -1,646 |
| Financing Cash Flow | $337,113 | $337,328 | $337,480 | $338,049 | $58,118 |
| Beginning Cash Position | 35,212 | 35,212 | 35,212 | 35,212 | 38,289 |
| End Cash Position | 97,173 | 105,227 | 132,192 | 224,857 | 35,212 |
| Net Cash Flow | $61,961 | $70,015 | $96,980 | $189,645 | $-3,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | -114,250 | -77,189 | -49,700 | -25,525 | -52,410 |
| Capital Expenditure | -2,205 | -1,673 | -1,571 | -543 | -621 |
| Free Cash Flow | -116,455 | -78,862 | -51,271 | -26,068 | -53,031 |